| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
49,371,000 | 49,371,000 | 49,162,000 | 44,097,000 | 39,665,000 |
| Cost of Revenue
|
-34,173,000 | -34,173,000 | -35,169,000 | -31,992,000 | -29,348,000 |
|
Gross Profit
|
15,198,000 | 15,198,000 | 13,992,000 | 12,105,000 | 10,317,000 |
|
Operating Income/Expenses
|
-12,098,000 | -12,098,000 | -11,225,000 | -10,136,000 | -9,288,000 |
|
Total Operating Profit/Loss
|
3,100,000 | 3,100,000 | 2,767,000 | 1,969,000 | 1,029,000 |
| Total Net Finance Income/Expense
|
-105,000 | -105,000 | -91,000 | -115,000 | -75,000 |
| Net Investment Income
|
778,000 | 778,000 | 363,000 | 326,000 | 826,000 |
| Irregular Income/Expenses
|
-604,000 | -604,000 | 99,000 | 1,000 | -133,000 |
|
Other Income/Expense, Non-Operating
|
106,000 | 106,000 | 57,000 | 49,000 | 46,000 |
|
Non-Operating Income/Expenses, Total
|
175,000 | 175,000 | 428,000 | 261,000 | 664,000 |
|
Pretax Income
|
3,276,000 | 3,276,000 | 3,197,000 | 2,231,000 | 1,693,000 |
| Provision for Income Tax
|
-737,000 | -737,000 | -1,187,000 | -987,000 | -751,000 |
|
Net Income from Continuing Operations
|
2,539,000 | 2,539,000 | 2,010,000 | 1,244,000 | 942,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
2,538,000 | 2,538,000 | 2,009,000 | 1,244,000 | 941,000 |
|
Non-Controlling/Minority Interests
|
-2,000 | -2,000 | 0 | 68,000 | 78,000 |
|
Net Income after Non-Controlling/Minority Interests
|
2,536,000 | 2,536,000 | 2,009,000 | 1,312,000 | 1,020,000 |
|
Net Income Available to Common Stockholders
|
2,536,000 | 2,536,000 | 2,009,000 | 1,312,000 | 1,020,000 |
|
Diluted Net Income Available to Common Stockholders
|
2,536,000 | 2,536,000 | 2,009,000 | 1,312,000 | 1,020,000 |
| Basic EPS
|
65.85 | 65.85 | 52.29 | 34.25 | 26.67 |
| Diluted EPS
|
65.83 | 65.83 | 52.28 | 34.25 | 26.67 |
|
Basic Weighted Average Shares Outstanding
|
38,521.28 | 38,521.28 | 38,427.80 | 38,306.57 | 38,245.22 |
|
Diluted Weighted Average Shares Outstanding
|
38,521.28 | 38,521.28 | 38,427.80 | 38,306.57 | 38,245.22 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
3,381,000 | 3,381,000 | 3,288,000 | 2,346,000 | 1,768,000 |
|
EBITDA
|
4,683,000 | 4,683,000 | 4,455,000 | 3,369,000 | 2,758,000 |
|
Normalized EBITDA
|
5,171,000 | 5,171,000 | 4,254,000 | 3,292,000 | 2,312,000 |
|
Normalized Income
|
3,425,000 | 3,425,000 | 3,071,000 | 2,144,000 | 1,255,000 |
|
Total Unusual Items
|
488,000 | 488,000 | -201,000 | -77,000 | -446,000 |
|
Total Unusual Items Excluding Goodwill
|
488,000 | 488,000 | -201,000 | -77,000 | -446,000 |
|
Tax Effect of Unusual Items
|
109,800 | 109,800 | -74,571 | -17,864 | -103,472 |
3/31/2023 - 1/1/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade